Pharming (PHAR) Other Working Capital Changes (2019 - 2026)
Pharming's (PHAR) quarterly Other Working Capital Changes came in at $4.1 million in Q4 2025, up 201.4% YoY from $1.3 million in Q4 2024, and up 201.4% on a QoQ basis from -$4.0 million in Q4 2024.
Analysis
Pharming (PHAR) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Pharming (PHAR) has 7 years of Other Working Capital Changes data on file, last reported at $4.1 million in Q4 2025.
- Quarterly Other Working Capital Changes rose 201.4% year-over-year to $4.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.0 million (up 73.27% YoY) and the FY2025 annual result came in at $1.2 million, changed N/A from the prior year.
- Other Working Capital Changes rose to $4.1 million in Q4 2025, from -$4.0 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $4.1 million in Q4 2025 to a low of -$4.0 million in Q4 2023.
- A 5-year average of -$1.2 million and a median of -$918000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2021 — Other Working Capital Changes tumbled 24189.19% — and 2025, when it jumped 201.4%.
- Tracing PHAR's Other Working Capital Changes over 5 years: stood at -$554000.0 in 2021, then slumped by 45.67% to -$807000.0 in 2022, then tumbled by 400.37% to -$4.0 million in 2023, then increased by 0.74% to -$4.0 million in 2024, then jumped by 201.4% to $4.1 million in 2025.
- The last three Other Working Capital Changes figures came in at $4.1 million (Q4 2025), -$4.0 million (Q4 2024), and -$918000.0 (Q3 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Pharming | 781.07 Mn | 621.57 Mn | 141.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.70 Mn |
| Jun 30, 2026 | -17.70 Mn |
| Dec 31, 2025 | -21.46 Mn |
| Dec 31, 2025 | -21.46 Mn |
| Dec 31, 2024 | -10.07 Mn |
| Dec 31, 2024 | -10.07 Mn |
| Sep 30, 2024 | 7.35 Mn |
| Sep 30, 2024 | 7.35 Mn |
| Jun 30, 2024 | -10.33 Mn |
| Jun 30, 2024 | -10.33 Mn |
| Dec 31, 2023 | -16.96 Mn |
| Dec 31, 2023 | -16.96 Mn |
| Sep 30, 2023 | -4.56 Mn |
| Sep 30, 2023 | -4.56 Mn |
| Jun 30, 2023 | -11.01 Mn |
| Jun 30, 2023 | -11.01 Mn |
| Dec 31, 2022 | -387,000.00 |
| Dec 31, 2022 | -387,000.00 |
| Sep 30, 2022 | 2.40 Mn |
| Sep 30, 2022 | 2.40 Mn |